Skip to main content

SAT0241 Patients' perspective on the efficacy and risks of glucocorticoids in ra – an initiative under the gloria project

Publication ,  Conference
Carvalho, PD; Goel, N; Voshaar, M; Boers, M; Silva, JAPD
Published in: Annals of the Rheumatic Diseases
June 2018

Duke Scholars

Published In

Annals of the Rheumatic Diseases

DOI

ISSN

0003-4967

Publication Date

June 2018

Volume

77

Start / End Page

982 / 982

Publisher

Elsevier BV

Related Subject Headings

  • Arthritis & Rheumatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1107 Immunology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Carvalho, P. D., Goel, N., Voshaar, M., Boers, M., & Silva, J. A. P. D. (2018). SAT0241 Patients' perspective on the efficacy and risks of glucocorticoids in ra – an initiative under the gloria project. In Annals of the Rheumatic Diseases (Vol. 77, pp. 982–982). Elsevier BV. https://doi.org/10.1136/annrheumdis-2018-eular.7041
Carvalho, P. D., N. Goel, M. Voshaar, M. Boers, and J. A. P. D. Silva. “SAT0241 Patients' perspective on the efficacy and risks of glucocorticoids in ra – an initiative under the gloria project.” In Annals of the Rheumatic Diseases, 77:982–982. Elsevier BV, 2018. https://doi.org/10.1136/annrheumdis-2018-eular.7041.
Carvalho PD, Goel N, Voshaar M, Boers M, Silva JAPD. SAT0241 Patients' perspective on the efficacy and risks of glucocorticoids in ra – an initiative under the gloria project. In: Annals of the Rheumatic Diseases. Elsevier BV; 2018. p. 982–982.
Carvalho, P. D., et al. “SAT0241 Patients' perspective on the efficacy and risks of glucocorticoids in ra – an initiative under the gloria project.” Annals of the Rheumatic Diseases, vol. 77, Elsevier BV, 2018, pp. 982–982. Crossref, doi:10.1136/annrheumdis-2018-eular.7041.
Carvalho PD, Goel N, Voshaar M, Boers M, Silva JAPD. SAT0241 Patients' perspective on the efficacy and risks of glucocorticoids in ra – an initiative under the gloria project. Annals of the Rheumatic Diseases. Elsevier BV; 2018. p. 982–982.

Published In

Annals of the Rheumatic Diseases

DOI

ISSN

0003-4967

Publication Date

June 2018

Volume

77

Start / End Page

982 / 982

Publisher

Elsevier BV

Related Subject Headings

  • Arthritis & Rheumatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1107 Immunology
  • 1103 Clinical Sciences